Three experiments were conducted to evaluate the effect of in ovo administration of FloraMax R -B11 (FM) on Marek´s disease (MD) herpesvirus of turkeys (HVT) vaccine protective efficacy, hatchability, microbiota composition, morphometric analysis, and Salmonella enteritidis (SE) infection in chickens. Experiment 1 consisted of 3 trials. In trials 1 and 2, d 18 White Leghorn 15I 5 x7 1 embryos were randomly distributed in 4 groups: 1) HVT vaccinated in ovo and no Marek's disease virus (MDV) challenge; 2), HVT + FM vaccinated in ovo and no MDV challenge; 3) HVT vaccinated in ovo and challenge with virulent MDV (vMDV; strain 583A); and 4), HVT + FM vaccinated in ovo and challenge with vMDV. Trial 3 was designed exactly the same as Experiment 1 but chicks were challenged with very virulent MDV (vvMDV; strains Md5 and 612). Birds were monitored until 8 wk of age, and tested for MD incidence. Experiment 2 consisted of 3 trials. In each trial, d 18 broiler embryos were injected in ovo with either saline or FM to measure hatchability and gastrointestinal bacterial composition. In Experiment 3, d 18 broiler embryos were injected in ovo with either saline or FM. All chickens that hatched were orally gavaged with SE at hatch and kept for 7 d to monitor post-hatch BW. No significant difference (P > 0.05) between MD percentage in birds vaccinated with HVT alone or HVT + FM were observed in Experiment 1. In Experiment 2, probiotic did not negatively affect hatchability, but did reduce lactose positive Gram-negative bacteria. Further, increase in BW was associated with higher villi surface area in the ileum in chickens that received the probiotic as well as a significant reduction in the SE incidence in Experiment 3. These results suggest that in ovo administration of FM does not negatively impact the ability of HVT to protect against MD or hatchability of chickens, but improves BW during the first 7 d of life and decreases SE recovery in chickens.
INTRODUCTION
Bacterial communities living and colonizing in the gastrointestinal tract of animals outnumber total somatic cells of metazoans by an estimated 10-fold (Neish, 2009) . Today, the microbiome is recognized as the "forgotten organ," operating like an organ within the host and orchestrating numerous physiological and biological functions that have a profound impact on the balance between health and disease (O'Hara and Shanahan, 2006; Tellez, 2014) . Early establishment of C 2017 Poultry Science Association Inc. Received August 8, 2016. Accepted December 13, 2016. 1 Corresponding author: gtellez@uark.edu the microbiome has been reported to improve the assembly of the gut-associated lymphoid tissue (Martin et al., 2010) , intervene in the development of the immune system (McFall-Ngai, 2007) , maintain mucosal barrier integrity (Duerkop et al., 2009) , modulate proliferation of enterocytes (Moran, 2007) , adjust blood flow (Sekirov et al., 2010) , regulate the enteric nervous system (Tlaskalová-Hogenová et al., 2011) , and improve digestion of nutrients (Dass et al., 2007; Walter et al., 2011; Qiu et al., 2012) . Essential colonization of these bacterial populations starts at birth/hatch, and is followed by progressive assembly of a complex and dynamic microbial society (Di Mauro et al., 2013) .
Under commercial conditions, millions of chickens and turkeys hatch in a hostile environment, and are exposed for several h to heat stress and potential 2074 pathogenic bacteria in the hatcheries. Increased stress along with the potential abundance of pathogens in the hatching cabinet leads to ideal conditions for pathogen colonization. It is generally accepted that the natural route of transmission of zoonotic pathogens such as Salmonella, is fecal-oral (White et al., 1997; Galanis et al., 2006) . However, published studies also have suggested that airborne transmission of Salmonella in poultry is possible (Wathes et al., 1988; Baskerville et al., 1992; Leach et al., 1999; Fallschissel et al., 2009) . Understanding the anatomical and immunological defenses of the avian respiratory tract helps to clarify this issue. Architecture of the avian respiratory tract is an important component to susceptibility and resistance to infectious agents. In day-old chickens and turkeys, no or very few infiltrating lymphocytes are seen in the primary bronchi region (Fagerland and Arp, 1990; Smialek et al., 2011) and it is not until 3 to 4 wk of age that the lymphoid nodules are developed at these locations (Fagerland and Arp, 1993; Drolet et al., 2010) . During the following wk, the number of IgG, IgA, or IgM producing cells continues to increase; however, the bronchial-associated lymphoid tissue (BALT) is not mature until chickens are 6 to 8 wk old (Bienenstock, 1980; Bienenstock and McDermott, 2005; De Geus, 2012) . Hence, commercial neonate poultry are extremely susceptible to airborne pathogens, regardless of whether or not they are respiratory or enteric bacteria (Arshad et al., 1998) . In support of these findings, our laboratory has recently showed that transmission by the fecal-respiratory route is a viable portal of entry for Salmonella (Kallapura et al., 2014a,b,c) . This mode of infection could explain some clinical expression of relatively low-dose infectivity under field conditions in relation to the high oral challenge dose that is typically required for infection through the oral route in laboratory studies. This also supports previous studies demonstrating fan driven spread of Salmonella within the hatching cabinet and hatchery incubators (Hashemzadeh et al., 2010) .
Over a century ago, Eli Metchnikoff proposed the ground-breaking idea to ingest viable bacteria to improve health (Metchnikoff, 1908) . This concept is more appealing today, since antimicrobial resistant bacteria have become a problem in many countries (Kiser, 1976; Dahiya et al., 2006; Teillant and Laxminarayan, 2015) . The imminent ban of antibiotics in animal feed creates a challenging scenario for expansion of alternative prophylactics (Parker, 1990; Dahiya et al., 2006; You and Silbergeld, 2014) . Probiotics and direct-fed microbials are becoming accepted as one of the best tools on keeping gastrointestinal health and promoting performance in poultry raised without antibiotics (Dominguez-Bello and Blaser, 2008) . In addition to improving intestinal microbial balance, metabolism, and gut integrity (Isolauri et al., 2002; Salminen and Isolauri, 2006) , studies also have shown that some probiotics have anti-inflammatory (Borchers et al., 2009; Lyte, 2011) , anti-oxidant (Farnell et al., 2006; Tao et al., 2006; Zareie et al., 2006; Segawa et al., 2011; Howarth and Wang, 2013) , and enhaced barrier integrity properties (Yu et al., 2012) . Furthermore, several researchers have confirmed benefits of probiotics on innate immunity (Alvarez-Olmos and Oberhelman, 2001; Vanderpool et al., 2008; Molinaro et al., 2012) as well as humoral immunity (Arvola et al., 1999; Haghighi et al., 2006; Howarth and Wang, 2013) . FloraMax R -B11 is a defined lactic acid bacteria (LAB) probiotic culture that has demonstrated an accelerated development of normal microflora in chickens and turkeys. It provides increased resistance to Salmonella spp. infections (Farnell et al., 2006; Higgins et al., 2007 Higgins et al., , 2008 Higgins et al., , 2010 Vicente et al., 2007; Menconi et al., 2011 Menconi et al., , 2013 Tellez et al., 2012; Biloni et al., 2013; Delgado et al., 2014) , reduces idiopathic diarrhea in commercial turkey brooding houses (Higgins et al., 2005) , and increases performance and reduces costs in poultry Vicente et al., 2008) . However, no studies have been evaluated for administration of FloraMax R -B11 in ovo, and the only practical and reliable way to evaluate this route of administration would be mixing it with the diluent of the Marek's disease (MD) vaccine. Hence, the objective of the present study was to evaluate the effect of the in ovo administration of FloraMax R -B11 on MD vaccine herpesvirus of turkeys (HVT) protective efficacy, hatchability, microbiota composition, morphometric analysis, and SE infection in chickens.
MATERIAL AND METHODS

Probiotic Culture
FloraMax R -B11 (Pacific Vet Group USA Inc., Fayetteville, AR) is a defined probiotic culture derived from poultry gastrointestinal origin that contains proprietary strains of LAB. This probiotic was evaluated in 3 experiments. The objectives of Experiment 1 were to evaluate the effect of this probiotic on HVT Marek´s vaccine virus stability and incidence of disease in White Leghorn 15I 5 x7 1 chickens in 3 independent trials. The aims of Experiment 2 were to evaluate the effect of in ovo application of this probiotic on hatchability and microbial composition in the gastrointestinal tract of hatching broiler chickens in 3 independent trials. The objectives of Experiment 3 were to evaluate the in ovo administration of this probiotic culture on hatchability, body weight, Salmonella enteritidis recovery, and morphometric analysis of the duodenum and ileum in broiler chickens.
Experiment 1 In Ovo Evaluation of FloraMax R -B11 on Marek´s Disease HVT Vaccine
Chickens and Viruses. Maternal-antibody-negative, White Leghorn 15I 5 x7 1 chickens were used in these experiments (Bacon et al., 2000) . These MD-susceptible chickens were from an SPF breeding flock with no MD vaccinations or exposure that tested negative for Marek's disease virus (MDV) antibodies, exogenous avian leukosis virus, or reticuloendotheliosis virus by routine surveillance testing. All birds were housed in negative-pressure Horsfall-Bauer isolators, and experiments were conducted following approval by the USDA Avian Disease and Oncology Laboratory (ADOL) Animal Care and Use Committee. Viruses were propagated on primary duck embryo fibroblasts (DEF) maintained in Leibovitz L-15 medium plus McCoy 5A medium (1:1), supplemented with 2.5% bovine serum and antibiotics (Witter et al., 1980) . In trials 1 and 2, chickens were challenged with the MDV strain 583, a virulent (v) strain. In trial 3, chickens were challenged with MDV strains Md5 or 612, both very virulent (vv). HVT is a commercial vaccine, and was prepared and utilized as recommended by the manufacturer (Marek's Disease Vaccine Merial Select, Serotype 3, Live Virus, HVT)
Experimental Design Experiment 1 Consisted of Three Independent Trials
Trial 1 and Trial 2. Chicks were randomly distributed into 4 groups (each with 17 birds) in 2 independent trials: 1) HVT vaccinated in ovo and no MDV challenge; 2) HVT + FloraMax R -B11 vaccinated in ovo and no MDV challenge; 3) HVT vaccinated in ovo and challenged with MDV; and 4) HVT + FloraMax R -B11 vaccinated in ovo and challenged with MDV. MD vaccine was administered in ovo at the manufacturer recommended dosage either alone or with FloraMax R -B11 (10 4 cfu). Birds were monitored until 8 wk of age, then humanely euthanized and evaluated for MD incidence. Chickens were considered MD positive if peripheral nerve enlargements, tumors, or both were present at necropsy. When enlarged nerves or gross tumors were in question, tissue samples were collected and processed for microscopic evaluation. Chicks that died during the first wk of placement were considered nonspecific chick mortalities and were excluded from the experiment.
Trial 3. The identical conditions were used as described for Experiment 1 except that MDV strains Md5 and 612 were used instead of strain 583A and the experiment included only one trial.
Experiment 2 Effect of In ovo Application of Floramax R -B11 on Hatchability and Microbiota Composition
Experiment 2 consisted of 3 independent trials. Eighteen-day-old embryos were obtained from CobbVantress (Siloam Springs, AR). In each trial, eggs were candled and inoculated with either saline or 10 4 cfu of FloraMax R -B11 via in ovo injection into the amnion. The 2 treatment groups were placed in separate hatchers to avoid cross contamination. On d 21, chicks were pulled from hatchers and hatchability was determined. In each trial, 12 chickens from each group were humanely euthanized to evaluate gastrointestinal composition on selective media as described below.
Enumeration of Bacteria
For trial 1, the whole gut (ventriculus to cecum) was aseptically removed. For trials 2 and 3, the fore gut (ventriculus to Meckel's diverticulum) and hind gut (Meckel's diverticulum to cecum) were removed separately. Sections were collected into sterile bags and homogenized. Samples were weighed and 1:4 wt/vol dilutions were made with sterile 0.9% saline. Ten-fold dilutions of each sample, from each group, were made in a sterile 96 well Bacti flat bottom plate and the diluted samples were plated on 2 different culture media to evaluate total number of LAB in Man Rogosa Sharpe (Difco TM Lactobacilli MRS Agar VWR cat. no. 90004-084, Suwanee, GA 30024) and total lactose positive Gram-negative bacteria in MacConkey (VWR cat. no. 89429-342, Suwanee, GA 30024).
Experiment 3 Evaluation of In ovo Administration of Floramax R -B11 on Body Weight, Salmonella Enteritidis Recovery, and Morphometric Analysis in Broiler Chickens
In Experiment 4, the challenge organism used in all experiments was a poultry isolate of Salmonella enterica (SE) serovar, enteritidis, bacteriophage type 13A, originally obtained from the USDA National Veterinary Services Laboratory, Ames, IA. This isolate was resistant to 25 μg/mL of novobiocin (NO, cat. no. N-1628, Sigma, St. Louis, MO) and was selected for resistance to 20 μg/mL of nalidixic acid (NA, Sigma) . For the present studies, 100 μL of SE from a frozen aliquot was added to 10 mL of tryptic soy broth (cat. no. 22092, Sigma) and incubated at 37
• C for 8 h, and passed 3 times every 8 h to ensure that all bacteria were in log phase growth. Post incubation, bacterial cells were washed 3 times with sterile 0.9% saline by centrifugation at 1,800 × g for 10 min, reconstituted in saline, quantified by densitometry with a spectrophotometer (Spectronic 20D+, Spectronic Instruments Thermo Scientific, Waltham, MA), and diluted to an approximate concentration of 10 8 cfu/mL. Concentrations of SE were further verified by serial dilution and plating on brilliant green agar (BGA, cat. no. 70134, Sigma) with NO and NA for enumeration of actual cfu used to challenge the chickens.
In this trial, 300 18-day-old embryos were received from Cobb-Vantress. At d 18, eggs were candled and inoculated with either saline or 10 4 cfu FloraMax R -B11 via in ovo injection into the amnion. The 2 treatment groups were placed in separate hatch cabinets in separate rooms to avoid cross contamination. On d 21, chicks were pulled from hatchers to measure hatchability. All chickens were then orally gavaged with SE on d of hatch (∼10 4 cfu/chick). Twenty-four h post inoculation (PI), 20 chickens were euthanized with carbon dioxide asphyxiation to determine SE intestinal colonization as described below. From these chickens, 5 samples also were taken to determine intestinal morphometric analysis as described below. BW was determined at d 1, 3, and 7. Chickens were provided ad libitum access to water and a balanced unmedicated corn-soybean diet meeting the nutrition requirements of poultry recommended by NRC (1994). All animal handling procedures were in compliance with the Institutional Animal Care and Use Committee at the University of Arkansas (approval number 16053).
Salmonella Recovery
Ceca-cecal tonsils (CCT) were homogenized and diluted with saline (1:4 by wt/vol) and 10-fold dilutions were plated on BGA with NO and NA, incubated at 37
• C for 24 h to enumerate total SE colony forming units. Following plating to enumerate total SE, the CCT samples were enriched in double strength tetrathionate enrichment broth and further incubated at 37
• C for 24 h to enrich salmonellae. Following this, enrichment samples were plated on BGA with NO and NA and incubated at 37
• C for 24 h to confirm presence/absence of typical lactose-negative colonies of Salmonella.
Intestinal Morphological Analysis
For enteric morphometric analysis, ileum and duodenum samples were collected (n = 5). A one-cm segment of the midpoint of the duodenum and the distal end of the lower ileum from each bird was removed and fixed in 10% buffered formaldehyde for 48 hours. Each of these intestinal segments was embedded in paraffin, and a 5-μm section of each sample was placed on a glass slide and stained with hematoxylin and eosin for examination under a light microscope. All morphological parameters were measured using the ImageJ software package (http://rsb.info.nih.gov/ij/). Ten replicate measurements for each variable studied were taken from each sample, and the average values were used in statistical analysis. Villus length (VL) was measured from the top of the villus to the top of the lamina propria (Yitbarek et al., 2013) . Crypt depth was measured from the base upward to the region of transition between the crypt and villus (Biloni et al., 2013) . Villus width (VW) was measured at the widest area of each villus, whereas the villus:crypt ratio was determined as the ratio of villus height (VH) to crypt depth. Villus surface area (VSA) was calculated using the formula (2π)(VW/2)(VL), (Sakamoto et al., 2000) .
Statistical Analysis
All data were subjected to one-way analysis of variance as a completely randomized design using the GLM procedure of SAS (SAS Institute, 2002) . Data are expressed as mean ± standard error. Significant differences among the means were determined using Duncan's multiple-range test at P < 0.05. MDV as well as SE incidence data were expressed as positive/total chickens (%), and the percent recovery of SE was compared using the chi-squared test of independence, testing all possible combinations to determine the significance (P ≤ 0.001) for these studies (Zar, 1984) .
RESULTS
This study addressed 3 major concerns: A) whether in ovo administration of FloraMax R -B11 mixed with MD vaccine would negatively impact vaccine efficacy in White Leghorn 15I 5 x7 1 chickens (Experiment 1); B) the effect of in ovo administration on hatchability and microbiota composition (Experiment 2); and C) the impact on Salmonella infections and morphometric analysis in broiler chickens (Experiment 3). Experiment 1 consisted of 3 independent replicates to determine if there was any difference when birds were vaccinated in ovo with HVT only or with HVT + FloraMax R -B11 followed by challenge with vMDV or vvMDV. The results of the in ovo evaluation of FloraMax R -B11 on HVT vaccine efficacy in trials 1 and 2 are summarized in Table 1 . In both experiments, there was no significant difference between % MD in birds vaccinated with HVT alone or HVT + FloraMax R -B11, although numerical differences between treatments suggest that probiotics may have slightly improved protection immunity in birds challenged with MDV strain 583. This potential benefit was not apparent when we used vvMDV strains (Md5 or 612) in trial 3 (Table 1) .
The effect of in ovo administration of the probiotic FloraMax R -B11 on hatchability in Experiment 2 is (Md5) 10/17 (59%) 9/17 (53%) vvMDV challenge (612) 11/17 (65%) 13/17 (76%)
Marek's disease HVT vaccine was administered in ovo at manufacturer labeled dosage alone or with FloraMax R -B11 (10 4 cfu/g). MDV challenge was administered at 5 d of age using 500 pfu vMDV strain 583 in Experiment 1, or 500 pfu vvMDV strains Md5 or 612, respectively. Birds were monitored until 8 wk of age, then euthanized and measured for MD incidence. P > 0.05. Table 2 . There was no significant difference in hatchability between embryos administered probiotics or the controls in any of the 3 independent trials of this experiment. The results of the effect of in ovo application of FloraMax-B11 R on microbial composition in the gastrointestinal tract of hatching broiler chickens in Experiment 2 are summarized in Table 3 . In trials 1 and 3, chickens treated with FloraMax R -B11 showed a significant reduction in lactose positive Gram-negative bacteria recovery when compared with the saline control group at d of hatch. In trial 2, the treated group had numerically lower recovery than the control group and in fact had reduced Gram negatives to non-recoverable numbers. With the exception of the hindgut in trial 2, a significant increase in the total number of LAB was observed in the probiotic group when compared with the saline treated group (Table 3) .
The results of in ovo administration of FloraMax R -B11 on hatchability, BW, and SE recovery in broiler chickens of Experiment 3 are summarized in Table 4 . In this experiment, no significant changes were observed in hatchability or the BW of the neonates when they were removed from the hatching cabinets; however, a significant increase in BW was observed in chickens that received the probiotic when compared with the saline control group on d 3 and 7 (Table 4) . Interestingly, chickens that received the probiotic, showed a significant reduction in the incidence and total SE cfu numbers recovered from CCT when compared with saline control chickens ( Table 4) .
The results of the effect of in ovo application of FloraMax R -B11 on morphometric analysis of the gastrointestinal tract of hatching broiler chickens of Experiment 3 are summarized in Table 5 . A numerical increase in VH, VW, and VSA was observed in the treated group when compared to the controls for the duodenum. Nevertheless, embryos that received the probiotic showed a significant increase in the villus:crypt depth ratio when compared with the saline control group. In the ileum, there was a significant increase in VH, VSA, and crypt depth in the probiotic treated group when compared to the control group. At d 18 eggs were candled and inoculated with either saline or FloraMax R -B11 via in ovo injection into the amnion. On d 21, chicks were pulled from the hatchers and for Experiment 1, the whole gut (ventriculus to cecum) was aseptically removed. For trials 2 and 3 the fore gut (ventriculus to Meckel's diverticulum) and hind gut (Meckel's diverticulum to cecum) were removed separately.
1 Samples were plated on MacConkey agar to evaluate total lactose positive Gram-negative bacteria. 2 Samples were plated on MRS agar to evaluate total lactic acid bacteria. Data is expressed as Log 10 of bacteria/g mean ± standard error. * Superscripts within columns for each plate indicate significant difference at P < 0.05, n = 12. 4 cfu/chick. Incidence data are expressed as positive/total chickens (%) at 24 h post inoculation (PI); asterisks indicate significant differences P < 0.001, n = 20/group. Log 10 SE/g of ceca content is expressed as mean ± standard error.
a,b Superscripts within columns indicate significant differences P < 0.05, n = 12/group. 
DISCUSSION
MD is a lymphoproliferative disease of domestic chickens caused by an oncogenic α-herpesvirus (Churchill and Biggs, 1967; Calnek, 2001 ). The disease is associated with lymphomas, neurologic manifestations, and immune suppression (Calnek, 2001) . Without a question, MD has been a major concern to the poultry industry for over half a century (Nair, 2005) , and the modern poultry industry as we know it today would not exist without the development of MD vaccines (Baigent et al., 2006; Gimeno, 2008; Parvizi et al., 2010; Silva et al., 2010; Dunn and Silva, 2012) . The virus is so abundant and stable in the environment that vaccination at the hatchery is the only effective method to control MD in commercial flocks (Witter et al., 1980; Baigent et al., 2006; Dunn et al., 2010) . Due to the significant economic and immunosuppression impact, modern commercial chickens are vaccinated before they leave the hatchery.
Although, we have reported the benefits of spray application of FloraMax R -B11 in the hatcheries , this is the first report of in ovo application of this defined probiotic, mixed with HVT vaccine simultaneously. One of the 2 major concerns we addressed in this study was whether in ovo administration of FloraMax R -B11 would negatively affect MD vaccine protective efficacy. The results of the trials in Experiment 1 demonstrated that there was no negative impact and even possibly a small improvement of the probiotic, depending on the MDV challenge strain. As far as we are aware, this is the first report showing the possibility of combining a probiotic with an in ovo MD vaccine showing no negative effect (Table 1) . The other major concern with in ovo application of FM was on broiler hatchability, but in every trial conducted in Experiment 2 the probiotic also showed no negative effects on hatchability (Table 2) .
In the present study, it was remarkable to observe that embryos, which received the probiotic before hatch, had a significant reduction in lactose positive Gram-negative bacteria when compared with saline treated chickens (Table 3) . There is extensive evidence demonstrating that this particular probiotic is able to control Salmonellae infections in poultry in both laboratory or commercial conditions (Farnell et al., 2006; Higgins et al., 2007 Higgins et al., , 2008 Higgins et al., , 2010 Vicente et al., 2007; Menconi et al., 2011 Menconi et al., , 2013 Tellez et al., 2012; Biloni et al., 2013; Delgado et al., 2014) . This current study further validated the probiotics efficacy via in ovo administration by reducing the recovery of SE when chickens were challenged at d of hatch and cultured 24 h later (Table 4) . These results are in agreement with the work of De Oliveira et al. (2014) who demonstrated that in ovo colonization with probiotic could become an important method to reduce Salmonella and other intestinal bacterial infections in poultry.
In Experiment 3, the significant increase in BW in treated chickens at d 3 and 7 (Table 4) were associated with significant morphometric changes in the duodenum and ileum observed at d 1 (Table 5 ). It is likely that the higher BW in the probiotic treated group was due to the increase in VH, leading to more VSA, leading to better nutrient absorption. These results are meaningful in context with the rapid early growth of broiler chicks. A newly hatched modern broiler chick increases its BW by 25% overnight and 5,000% by 5 wk, to 2 kg (Choct, 2009) . Similarly, it is also important to consider the productive life of broiler chickens. The full genetic potential of modern chickens starts at conception and the first 21 d of embryo development. During this period, variables such as temperature or oxygen are important and any problem related to them could cause a big impact later in life. Hence, the 21 d of embryogenesis plus the first 7 d of life of the chicken could potentially represent between 50 and 74% of the life of a commercial broiler chicken, depending on the time it is slaughtered (56 or 77 d) (Cherian, 2011) . Therefore, earlier administration of probiotics to embryos can have a profound impact on growth and overall health of the birds.
In summary, the results of the present study suggest in ovo administration of FloraMax R -B11 does not negatively affect HVT vaccine efficacy or hatchability of the chickens, but improves BW and intestinal integrity during the first 7 d of life while decreasing SE intestinal load in broiler chickens. Elucidating the role of FloraMax R -B11on other commercial MDV vaccine strains requires further investigation; however, studies to evaluate this probiotic with HVT vaccines under commercial conditions are currently underway.
